                               SEQUENCE LISTING                               

<110> Cellceutix Corporation

<120> Hybrid Compounds And Methods Of Making And Using The Same

<130> 141197.01802

<140> PCT/US13/73898
<141> 2013-12-09

<150> 61/735,114
<151> 2012-12-10

<160> 6                           

<170> PatentIn Ver. 2.1

<210> 1
<211> 24
<212> DNA
<213> Artificial Sequence

<220> 
<223> Description of Artificial Sequence: forward primer for hBD-2

<400> 1
gatgcctctt ccaggtgttt ttgg                                    24    


<210> 2
<211> 20
<212> DNA
<213> Artificial Sequence

<220> 
<223> Description of Artificial Sequence: reverse primer for hBD-2

<400> 2
ttgttccagg accacaggtg                                   20


<210> 3
<211> 28
<212> DNA
<213> Artificial Sequence

<220> 
<223> Description of Artificial Sequence: forward primer for IL-8

<400> 3
gcagctctgt gtgaaggtgc agttttgc                                    28


<210> 4
<211> 25
<212> DNA
<213> Artificial Sequence

<220> 
<223> Description of Artificial Sequence: reverse primer for IL-8

<400> 4
tttctgtgtt ggcgcagtgt ggtcc                                   25


<210> 5
<211> 19
<212> DNA
<213> Artificial Sequence

<220> 
<223> Description of Artificial Sequence: forward primer for b-2-
	 microglobulin 

<400> 5
ctccgtggcc ttagctgtg                                    19


<210> 6
<211> 21
<212> DNA
<213> Artificial Sequence

<220> 
<223> Description of Artificial Sequence: reverse primer for b-2-
	 microglobulin 

<400> 6
ttggagtacg ctggatagcc t       

